Phase I Trial of Twice Weekly IV IL [interleukin]-12 Plus Low-Dose Subcutaneous IL-2 in Patients With Advanced Malignancies
Phase of Trial: Phase I
Latest Information Update: 14 Aug 2006
At a glance
- Drugs Interleukin-12 (Primary) ; Interleukin-2 (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 28 Sep 2005 New trial record.